Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

38 results

Sort by

List item

Human medicine European public assessment report (EPAR): Rienso

Ferumoxytol, Anemia, Kidney Failure, Chronic
Date of authorisation: 15/06/2012, , Revision: 7, Withdrawn, Last updated: 13/07/2015
List item

Human medicine European public assessment report (EPAR): Ristempa

pegfilgrastim, Neutropenia
Date of authorisation: 13/04/2015, , Revision: 3, Withdrawn, Last updated: 07/03/2018
List item

Human medicine European public assessment report (EPAR): Rituzena (previously Tuxella)

rituximab, Lymphoma, Non-Hodgkin, Microscopic Polyangiitis, Leukemia, Lymphocytic, Chronic, B-Cell, Wegener Granulomatosis
Date of authorisation: 13/07/2017, , , Revision: 7, Withdrawn, Last updated: 08/07/2019
List item

Human medicine European public assessment report (EPAR): Solymbic

adalimumab, Arthritis, Psoriatic, Spondylitis, Ankylosing, Crohn Disease, Colitis, Ulcerative, Hidradenitis Suppurativa, Psoriasis, Arthritis, Rheumatoid
Date of authorisation: 22/03/2017, , , Revision: 2, Withdrawn, Last updated: 05/03/2019
List item

Human medicine European public assessment report (EPAR): Thorinane

enoxaparin sodium, Venous Thromboembolism
Date of authorisation: 14/09/2016, , , Revision: 2, Withdrawn, Last updated: 24/10/2019
List item

Human medicine European public assessment report (EPAR): Valtropin

somatropin, Turner Syndrome, Dwarfism, Pituitary
Date of authorisation: 24/04/2006, , Revision: 5, Withdrawn, Last updated: 14/08/2012
List item

Human medicine European public assessment report (EPAR): Varuby

rolapitant, Vomiting, Nausea, Cancer
Date of authorisation: 19/04/2017, , Revision: 3, Withdrawn, Last updated: 02/03/2020
List item

Human medicine European public assessment report (EPAR): Vibativ

telavancin, Pneumonia, Bacterial, Cross Infection
Date of authorisation: 02/09/2011, , Revision: 10, Withdrawn, Last updated: 16/05/2018
List item

Human medicine European public assessment report (EPAR): Vitekta

elvitegravir, HIV Infections
Date of authorisation: 13/11/2013, , Revision: 4, Withdrawn, Last updated: 29/05/2017
List item

Human medicine European public assessment report (EPAR): Zalmoxis

Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (ΔLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2), Hematopoietic Stem Cell Transplantation, Graft vs Host Disease
Date of authorisation: 18/08/2016, , Revision: 1, Withdrawn, Last updated: 14/02/2020
List item

Human medicine European public assessment report (EPAR): Zinbryta

daclizumab, Multiple Sclerosis
Date of authorisation: 01/07/2016, , Revision: 8, Withdrawn, Last updated: 28/06/2018
List item

Human medicine European public assessment report (EPAR): Zontivity

vorapaxar sulfate, Myocardial Infarction
Date of authorisation: 19/01/2015, , Revision: 2, Withdrawn, Last updated: 20/09/2017
List item

Human medicine European public assessment report (EPAR): Zurampic

lesinurad, Hyperuricemia
Date of authorisation: 18/02/2016, , Revision: 4, Withdrawn, Last updated: 31/07/2020